January 23, 2011

FDA Clears Siemens Innovance D-Dimer Test to Exclude DVT

January 24, 2011—Siemens Healthcare Diagnostics (Deerfield, IL) announced that the US Food and Drug Administration has cleared the company's Innovance D-dimer blood test to exclude deep vein thrombosis and pulmonary embolism in patients for whom a physician's pretest probability assessment indicates a nonhigh probability of embolism. The expanded use of this test helps physicians provide more timely patient diagnosis in high-risk and emergency care situations. The fully automated Siemens D-dimer blood test is performed on the company's Sysmex and BCS family of blood coagulation systems. The test benefits clinical laboratories of all types and sizes and can be used in both routine and emergency care settings, the company stated.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

January 23, 2011

FDA Clears Siemens Innovance D-Dimer Test to Exclude DVT

Current Issue

Keep In Touch